OQROGet OQRO Pro
Insider trade

BioLife Solutions, Inc. (BLFS)Officer sold ~$10K

Aby J. Mathew, Officer at BioLife Solutions, Inc., sold ~$10K of BioLife Solutions, Inc. shares.

~$10K
Approx. value · 405 sh @ $25.59
349K
Holds after · shares reported
Traded
Jan 6, 2026
Filed
Jan 8, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 11, 2025InsiderCEO sold ~$926K of BLFS shares in the open market
  2. Nov 12, 2025InsiderCEO sold ~$865K of BLFS shares in the open market
  3. Nov 13, 2025InsiderCEO sold ~$789K of BLFS shares in the open market
  4. Nov 19, 2025InsiderDirector sold ~$12K of BLFS shares in the open market
  5. Nov 20, 2025InsiderDirector sold ~$111K of BLFS shares in the open market
  6. Nov 21, 2025InsiderDirector sold ~$26K of BLFS shares in the open market
  7. Nov 25, 2025Insider · 7 peopleInsiders: 7 sales (~$113K)
  8. Nov 26, 2025InsiderDirector sold ~$54K of BLFS shares in the open market
  9. Dec 4, 2025InsiderCFO sold ~$772K of BLFS shares in the open market
  10. Dec 9, 2025Insider · 5 peopleInsiders: 5 sales (~$70K)
  11. Dec 15, 2025Insider · 2 peopleInsiders: 2 sales (~$67K)
  12. Jan 6, 2026 · this disclosureInsiderOfficer sold ~$10K of BLFS shares in the open market

What came next

  1. Jan 6, 2026Insider · 4 peopleInsiders: 4 sales (~$49K)
  2. Jan 8, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 8, 2026, Karen Foster, the Chief Quality and Operations Officer of BioLife Solutions, Inc. (the “Company”), provided notice of her decision to retire from her position as Chief Quality and Operations Officer of the Company, effective March 31, 2026.”
  3. Jan 12, 2026Company filing · Form 8-K · ResultsReported its results
  4. Feb 26, 2026Company filing · Form 8-K · ResultsReported its results
  5. Mar 3, 2026Insider · 6 peopleInsiders: 6 sales (~$46K)
  6. Mar 5, 2026Insider · Their largest sale since 2020Officer sold ~$1.95M of BLFS shares in the open market
  7. Mar 9, 2026InsiderOfficer sold ~$10K of BLFS shares in the open market
  8. Mar 23, 2026InsiderOfficer sold ~$49K of BLFS shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for BioLife Solutions, Inc.

For BioLife Solutions, Inc., OQRO holds 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BLFS page.

Other recent filings by Aby J. Mathew, EVP & Chief Scientific Officer

The full history of Aby J. Mathew, EVP & Chief Scientific Officer is on the profile page.

How this filing works

Other disclosures at BioLife Solutions, Inc.

Everything OQRO holds on this company is on its BLFS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data